BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 2008
View Archived Issues
Insights into the mechanism of action of maspin
Read More
Novel compounds for gastrointestinal disorders revealed in recent patents
Read More
Recent Daiichi Sankyo patents impart new coagulation factor Xa inhibitors
Read More
Novel agents for rheumatoid arthritis disclosed in recent patent literature
Read More
Non-brain-penetrant CB1 antagonists reduce weight in vivo
Read More
CRADA extension for BioDiem's live attenuated influenza vaccine program
Read More
Amorfix shows efficacy of DSE monoclonal antibodies in ASL mouse model
Read More
Lorus Therapeutics rounds up Q1 developments
Read More
ACE-031 begins phase I testing for loss of muscle
Read More
Peplin completes acquisition of Neosil for USD 6.7 million in an all-stock transaction
Read More
Pipex Pharmaceuticals changes name to Adeona Pharmaceuticals
Read More
FDA issues complete response to AMAG's NDA for ferumoxytol
Read More
FDA puts back PDUFA date for Takeda's TAK-390MR NDA by three months
Read More
Daiichi Sankyo acquires 52.5% of the equity share capital of Ranbaxy for USD 736 million
Read More
Peregrine completes enrollment in first stage of phase II trial of bavituximab in NSCLC
Read More
Biotec Pharmacon presents update on development of SBG
Read More
Archemix and Lilly sign agreement for R&D and intellectual property in aptamers
Read More
4SC reports results from phase I trial with cancer drug candidate 4SC-201
Read More
Avigen's AV-650 did not meet efficacy endpoints in phase IIb MS trial
Read More
Discovery submits complete response to May 2008 FDA approvable letter for Surfaxin
Read More
Raptor initiates patient dosing in phase IIa clinical trial of cysteamine in NASH
Read More
GeoVax ships DNA and MVA vaccines to HVTN for phase IIa human clinical trial
Read More
Novartis is to acquire pulmonary business from Nektar for USD 115 million
Read More
Gastrointestinal prokinetic 5-HT4 receptor agonist DA-6566 described
Read More
UPLIFT study reveals long-term effects of tiotropium in COPD patients
Read More
Saiko-keishi-to relieves pain in patients with classical trigeminal neuralgia
Read More
